advertisement
 

  Back to Current Daily Care News Daily Care News from 2004

Daily Care News from 2004

  1. [New!] A Two-Center Randomized Controlled Feasibility Trial of Insulin Pump Therapy in Young Children With Diabetes. (26 December 2004)
  2. [New!] Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. (26 December 2004)
  3. [New!] Relationships Between Hyperglycemia and Cognitive Performance Among Adults With Type 1 and Type 2 Diabetes. (26 December 2004)
  4. [New!] Randomized Controlled Clinical Trial of Glargine Versus Ultralente Insulin in the Treatment of Type 1 Diabetes. (26 December 2004)
  5. [New!] The low-AGE content of low-fat vegan diets could benefit diabetics - though concurrent taurine supplementation may be needed to minimize endogenous AGE production. (26 December 2004)
  6. [New!] The Relationship of Disordered Eating Habits and Attitudes to Clinical Outcomes in Young Adult Females With Type 1 Diabetes. (26 December 2004)
  7. [New!] Predictors of Health Care Costs in Adults With Diabetes. (26 December 2004)
  8. [New!] Standardisation of glycated haemoglobin. (26 December 2004)
  9. [New!] The number of unexpected HbA variants may be a greater problem in routine practice than is generally realized. (26 December 2004)
  10. [New!] Aspirin use among adults with diabetes: recent trends and emerging sex disparities. (26 December 2004)
  11. [New!] Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. (26 December 2004)
  12. [New!] Cardiac risk factors in patients with diabetes mellitus and major depression. (26 December 2004)
  13. [New!] Diabetes in children and young adults in Waikato Province, New Zealand: outcomes of care. (26 December 2004)
  14. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. (19 December 2004)
  15. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. (19 December 2004)
  16. New Form of Urinary Albumin in Early Diabetes. (19 December 2004)
  17. One Hour versus Two Hours Postprandial Glucose Measurement in Gestational Diabetes: A Prospective Study. (19 December 2004)
  18. Serious Psychological Distress Among Persons With Diabetes - New York City, 2003. (19 December 2004)
  19. A rational clinical approach to suspected insulin allergy: status after five years and 22 cases. (19 December 2004)
  20. Insulin Pump Helps Kids With Diabetes. (12 December 2004)
  21. Accuracy in discriminating blood glucose levels in a sample of children with type 1 diabetes. (12 December 2004)
  22. Growth, growth factors and diabetes. (12 December 2004)
  23. Mealtime interactions in families of pre-schoolers with type 1 diabetes. (12 December 2004)
  24. The participation roles of children and adolescents in the dietary counseling of diabetics. (12 December 2004)
  25. Adjusting insulin doses: from knowledge to decision. (12 December 2004)
  26. Promoting glycemic control through diabetes self-management: evaluating a patient activation intervention. (12 December 2004)
  27. Can patients tell when they are unwanted? (12 December 2004)
  28. Illness through the eyes of the child: the development of children's understanding of the causes of illness. (12 December 2004)
  29. Ponderal gain, waist-to-hip ratio, and pubertal development in girls with type-1 diabetes mellitus. (12 December 2004)
  30. Direct costs of care in Germany for children and adolescents with diabetes mellitus in the early course after onset. (12 December 2004)
  31. Social-psychological correlates of peer victimization in children with endocrine disorders. See also Kids With Diabetes Often Bullied. (12 December 2004)
  32. Unexpected and unexplained deaths among young Norwegian patients with diabetes mellitus. (12 December 2004)
  33. Reversible cognitive deterioration after a single episode of severe hypoglycaemia: a case report. (5 December 2004)
  34. Diabetic coma and hypoglycemia in children. What to do when in an emergency. (5 December 2004)
  35. Persistence of Benefits of Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes: A Follow-up Report. (5 December 2004)
  36. The impact of physiological, therapeutic and psychosocial variables on glycemic control in youth with type 1 diabetes mellitus. (5 December 2004)
  37. Vulvovaginal candidiasis in children and adolescents with type 1 diabetes mellitus. (5 December 2004)
  38. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. (5 December 2004)
  39. Persistent poor glycaemic control in adult Type 1 diabetes. A closer look at the problem. (5 December 2004)
  40. Introductory Experience with the Continuous Glucose Monitoring System (CGMS(R); Medtronic Minimed(R)) in Detecting Hyperglycemia by Comparing the Self-Monitoring of Blood Glucose (SMBG) in Non-Pregnant Women and in Pregnant Women with Impaired Glucose Tolerance and Gestational Diabetes. (5 December 2004)
  41. Managed Care and Children With Special Health Care Needs. (5 December 2004)
  42. Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes. (28 November 2004)
  43. Continuous Glucose Monitoring and the Reality of Metabolic Control in Preschool Children With Type 1 Diabetes. (28 November 2004)
  44. Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device. (28 November 2004)
  45. Insulin therapy and hypoglycaemia: the size of the problem. (28 November 2004)
  46. Nocturnal hypoglycaemia in type 1 diabetes-consequences and assessment. (28 November 2004)
  47. Asymptomatic hypoglycaemia: identification and impact. (28 November 2004)
  48. UK Children failed in diabetes test. For additional information, see National Paediatric Diabetes Audit. (28 November 2004)
  49. Outcomes in Type 1 Diabetic Pregnancies. (28 November 2004)
  50. Factors Associated With Preterm Delivery in Women With Type 1 Diabetes. (28 November 2004)
  51. Trends in Cardiovascular Complications of Diabetes. (28 November 2004)
  52. Conference calls for coordinated national diabetes action plans. (28 November 2004)
  53. Early subclinical limited axial and large joint flexibility in type 1 diabetes mellitus adolescents. (28 November 2004)
  54. Radial Artery Tonometry Demonstrates Arterial Stiffness in Children With Type 1 Diabetes. (28 November 2004)
  55. C-Reactive Protein Levels Following Acute Myocardial Infarction: Effect of insulin infusion and tight glycemic control. (28 November 2004)
  56. Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease. (28 November 2004)
  57. Support network of adolescents with chronic disease: Adolescents' perspective. (21 November 2004)
  58. Insulin detemir : a review of its use in the management of type 1 and 2 diabetes mellitus. (21 November 2004)
  59. Heart disease in diabetic patients is undertreated. (21 November 2004)
  60. Psycho-educational interventions for children with chronic disease, parents and siblings: an overview of the research evidence base. (21 November 2004)
  61. Spitzer warns of overseas diabetes test strips in N.Y.. (21 November 2004)
  62. Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: A meta-analysis. (21 November 2004)
  63. In the lead article in the November 12, 2004 Wall Street Journal, entitled At Cigna, Some Patients Found Conflict of Interest in System, reporter Laura Johannes wrote that Dana Diabecare had set up a fake company to process insulin pump requests for Cigna, a major US health care insurance company. Specifically, the WSJ reported that "... doctors who wanted a pump from one of Dana's competitors for a Cigna-covered patient were forced to funnel their requests through a Dana employee. But the doctors didn't know this because the Dana employees used phony names and said they were 'benefit coordinators.'" Further, "Three state and federal agencies are in the early stages of probing Dana's operations." The WSJ requires subscriptions to access the story online. (14 November 2004)
  64. High doses of vitamin E supplements do more harm than good. (14 November 2004)
  65. Continuous subcutaneous insulin infusion during general anesthesia: a case report. (14 November 2004)
  66. Daily stress and glycaemic control in Type 1 diabetes: individual differences in magnitude, direction, and timing of stress-reactivity. (14 November 2004)
  67. Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials. (14 November 2004)
  68. Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes. (14 November 2004)
  69. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study. (14 November 2004)
  70. Beneficial Postprandial Effect Of A Small Amount Of Alcohol On Diabetes And Cardiovascular Risk Factors Modification By Insulin Resistance. Free full text available in PDF format. (14 November 2004)
  71. Preventing microalbuminuria in type 2 diabetes. (14 November 2004)
  72. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. (14 November 2004)
  73. Potential Adjunctive Therapies in Adolescents with Type 1 Diabetes Mellitus. (7 November 2004)
  74. Postprandial glucose regulation and diabetic complications. (7 November 2004)
  75. Online forum messages posted by adolescents with type 1 diabetes. (7 November 2004)
  76. Contributions of children to the care of adults with diabetes. (7 November 2004)
  77. Strategies: Play and Win Blood Sugar Game (NYT registration required) reports on The DAILY (Daily Automated Intensive Log for Youth) trial: a wireless, portable system to improve adherence and glycemic control in youth with diabetes. (7 November 2004)
  78. Strategies for managing the diabetic patient. (7 November 2004)
  79. Feelings About Blood Glucose Monitoring Affects HbA1c in Kids. See also The Blood Glucose Monitoring Communication Questionnaire: An instrument to measure affect specific to blood glucose monitoring. (31 October 2004)
  80. Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections: The impact of baseline A1c. (31 October 2004)
  81. Reduced Hospitalizations and Death Associated With Influenza Vaccination Among Patients With and Without Diabetes. Full text available in HTML and PDF formats. (31 October 2004)
  82. Weathering the Influenza Vaccine Crisis offers advice from The New England Journal of Medicine and includes an excellent graphic depicting the process of creating flu vaccine. (24 October 2004)
  83. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. (24 October 2004)
  84. Metformin and insulin in type 1 diabetes: the first step - Letter to the Editor. (24 October 2004)
  85. Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin. (24 October 2004)
  86. Insulin strategies for type 2 diabetes mellitus. (24 October 2004)
  87. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria. (24 October 2004)
  88. Antipsychotic Drugs Linked To Insulin Resistance In Children. (24 October 2004)
  89. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. (17 October 2004)
  90. Effects of Glycemic Control on Diabetes Complications and on the Prevention of Diabetes. Also available in PDF format. (17 October 2004)
  91. Targeting Plasma Glucose: Preprandial Versus Postprandial. Also available in PDF format. (17 October 2004)
  92. The Weighty Issue of Low-Carb Diets, or Is the Carbohydrate the Enemy? Also available in PDF format. (17 October 2004)
  93. Physical training may enhance beta-cell function in type 2 diabetes. (17 October 2004)
  94. Influence of patient literacy on the effectiveness of a primary care-based diabetes disease management program. (17 October 2004)
  95. Management of newly diagnosed diabetes: home or hospital? (10 October 2004)
  96. Diabetes patients' ability to estimate dietary carbohydrate content for use in a decision support system. (10 October 2004)
  97. Meta-analysis of the health effects of using the glycaemic index in meal-planning. (10 October 2004)
  98. Botox Treats Diabetic Gastrointestinal Disorder references The Treatment of Diabetic Gastroparesis With Botulinum Toxin Injection of the Pylorus. (10 October 2004)
  99. Oral glucose tolerance test in children and adolescents: Positives and pitfalls. (10 October 2004)
  100. Does tight control of blood glucose in pregnant women with diabetes improve neonatal outcomes? (10 October 2004)
  101. Lactation, diabetes, and nutrition recommendations. (10 October 2004)
  102. Risk of cesarean wound complications in diabetic gestations. (10 October 2004)
  103. Optimizing combination therapy for type 2 diabetes in adolescents and adults: A case-based approach. (10 October 2004)
  104. Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. (10 October 2004)
  105. Lyrica (Pregabalin) Offers Sustained Relief Of Peripheral Neuropathic Pain. (10 October 2004)
  106. Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy. (3 October 2004)
  107. Photonic Crystal Glucose-Sensing Material for Noninvasive Monitoring of Glucose in Tear Fluid. (3 October 2004)
  108. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. (3 October 2004)
  109. Reimbursement and costs of pediatric ambulatory diabetes care by using the resource-based relative value scale: is multidisciplinary care financially viable? (3 October 2004)
  110. Evaluation of a bedside blood ketone sensor: the effects of acidosis, hyperglycaemia and acetoacetate on sensor performance. (3 October 2004)
  111. Age related differences in individual quality of life domains in youth with type 1 diabetes. Free full text available in PDF format. (3 October 2004)
  112. Home blood glucose monitoring in type 2 diabetes. (3 October 2004)
  113. Variations in glucose self-monitoring during oral hypoglycaemic therapy in primary care. (3 October 2004)
  114. Diabetic Ketoacidosis in Type 1 and Type 2 Diabetes Mellitus: Clinical and Biochemical Differences. (3 October 2004)
  115. Treatment of hypertension in patients with diabetes. (3 October 2004)
  116. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. Free full text available in PDF format. (3 October 2004)
  117. Insulin analogs: progressing slowly. (3 October 2004)
  118. Long acting insulin analogs: possibly more stable glucose regulation. (3 October 2004)
  119. HbA1c in the monitoring of type 1 diabetic patients. (3 October 2004)
  120. Direct medical costs unequivocally related to diabetes in Italian specialized centers. (3 October 2004)
  121. A systematic critique of diabetes on the world wide web for patients and their physicians. (3 October 2004)
  122. Good physicians from the perspective of their patients. (3 October 2004)
  123. The Impact of a Decade of Changing Treatment on Rates of Severe Hypoglycemia in a Population-Based Cohort of Children With Type 1 Diabetes. (26 September 2004)
  124. A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 Countries. Results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study. (26 September 2004)
  125. Acute Hyperglycemia Alters Mood State and Impairs Cognitive Performance in People With Type 2 Diabetes. (26 September 2004)
  126. Validity of the non-mydriatic camera for diabetic retinopathy screening and analysis of retinopathy risk indicators. (26 September 2004)
  127. Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart. (26 September 2004)
  128. A 35 year old woman with diabetic nephropathy who wants a baby: case presentation. (26 September 2004)
  129. Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine. (19 September 2004)
  130. Facilitating access to glucometer reagents increases blood glucose self-monitoring frequency and improves glycaemic control: a prospective study in insulin-treated diabetic patients. (19 September 2004)
  131. Relation between sense of coherence and glycemic control in type 1 and type 2 diabetes. (19 September 2004)
  132. Hormonal Counterregulation during Severe Hypoglycaemia under Everyday Conditions in Patients with Type 1 and Insulin-Treated Type 2 Diabetes Mellitus. (19 September 2004)
  133. The DAILY (Daily Automated Intensive Log for Youth) trial: a wireless, portable system to improve adherence and glycemic control in youth with diabetes. (19 September 2004)
  134. Edutainment tools for initial education of type-1 diabetes mellitus - initial diabetes education with fun. (19 September 2004)
  135. Quality In Pediatric Nursing Care: Children's Expectations. (19 September 2004)
  136. Diagnostic algorithm and management of immune-mediated complications associated with subcutaneous insulin therapy. (19 September 2004)
  137. How often does decreased consciousness of hypoglycaemia occur in children and adolescents with diabetes type 1 and what are its consequences? (12 September 2004)
  138. Streptococcus group B (GBS)--characteristic, occurrence in children and adolescents with type 1 diabetes mellitus. (12 September 2004)
  139. Anemia in patients with type 1 diabetes. (12 September 2004)
  140. Prevalence of chronic diabetes complications in dependence on insulin therapy method in children and adolescents with type 1 diabetes. (12 September 2004)
  141. Memory matters: developmental differences in predictors of diabetes care behaviors. (12 September 2004)
  142. Day-to-day glucose variability during pregnancy in women with Type 1 diabetes mellitus: glucose profiles measured with the Continuous Glucose Monitoring System. (12 September 2004)
  143. Diabetic ketoacidosis: Predictors of outcome in a pediatric intensive care unit of a developing country. (12 September 2004)
  144. Readability Assessment of British Internet Information Resources on Diabetes Mellitus Targeting Laypersons. See also NHS Direct website too complicated for diabetes sufferers and Diabetes websites too complicated. (12 September 2004)
  145. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. (5 September 2004)
  146. Quality of life and coping behaviour in Type 1 diabetes mellitus: relationship with metabolic control. (5 September 2004)
  147. Glycemia and the quality of well-being in patients with diabetes. (5 September 2004)
  148. Body Composition in Adolescents with Type 1 Diabetes: Aspects of Glycaemic Control and Insulin Sensitivity. (5 September 2004)
  149. Serious illness in childhood: The different threats of cancer and diabetes from a parent perspective. (5 September 2004)
  150. The postprandial glucose profile in the diabetic pregnancy. (5 September 2004)
  151. Can education during pregnancy improve the perinatal outcome in diabetic pregnancies? (5 September 2004)
  152. Effect of iron deficiency anemia on the levels of hemoglobin a1c in nondiabetic patients. (5 September 2004)
  153. Embryonic Pig Cell Transplants Halt Rat Diabetes: Procedure Requires No Immune Suppression Drugs. (5 September 2004)
  154. Rates of Glucose Change Measured by Blood Glucose Meter and the GlucoWatch Biographer During Day, Night, and Around Mealtimes. (29 August 2004)
  155. Hypoglycaemia and driving in people with insulin-treated diabetes: adherence to recommendations for avoidance. (29 August 2004)
  156. BioCritque offers comments on Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. (29 August 2004)
  157. Effect of a High-Protein, Low-Carbohydrate Diet on Blood Glucose Control in People With Type 2 Diabetes. (29 August 2004)
  158. Researchers find way to detect dangerous brain swelling in diabetic children. See also Cerebral Edema in Childhood Diabetic Ketoacidosis; Natural history, radiographic findings, and early identification. (22 August 2004)
  159. Nocturnal hypoglycemia in patients with insulin-treated diabetes. (22 August 2004)
  160. Morbidity of hypoglycemia in type 1 diabetes. (22 August 2004)
  161. Exercise-induced and other daytime hypoglycemic events in patients with diabetes: prevention and treatment. (22 August 2004)
  162. Education and multidisciplinary team approach in childhood diabetes. (22 August 2004)
  163. Glycaemic control in a type 1 diabetes clinic for younger adults. (22 August 2004)
  164. Insulin glargine for type 2 diabetes. (22 August 2004)
  165. 'Urine testing is a waste of time': newly diagnosed Type 2 diabetes patients' perceptions of self-monitoring. (22 August 2004)
  166. Does moderately severe hypoglycemia cause cognitive dysfunction in children? (15 August 2004)
  167. Warning on complementary therapy. (15 August 2004) FDA issues critical letter to Dana Diabecare, claiming that its "... insulin infusion pumps are misbranded... " and citing a "... failure to establish adequate written Medical Device Reporting procedures ...." See also FDA Warns Insulin Pump Distributor. Dana has published a Statement from the CEO in response. (8 August 2004)
  168. New guideline for the NHS on the diagnosis and management of type 1 diabetes in children. (8 August 2004)
  169. How does dietary advice for diabetes management divide families? (8 August 2004)
  170. Diabetes - the best diet? (8 August 2004)
  171. Metabolic and Cardiovascular Parameters in Type 1 Diabetes at Extreme Altitude. (8 August 2004)
  172. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity - a problem that is no longer restricted to minority groups. (8 August 2004)
  173. Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors. (1 August 2004)
  174. Long-term evaluation of a structured outpatient education programme for intensified insulin therapy in patients with Type 1 diabetes: a 12-year follow-up. (1 August 2004)
  175. Treatment of Diabetic Ketoacidosis With Subcutaneous Insulin Aspart. (1 August 2004)
  176. Hypoglycaemic coma, a feared paroxysmal phenomenon in type 1 diabetic patient. (1 August 2004)
  177. Improved Plasma Glucose Control, Whole-Body Glucose Utilization, and Lipid Profile on a Low-Glycemic Index Diet in Type 2 Diabetic Men. (1 August 2004)
  178. The Incidence of Congestive Heart Failure in Type 2 Diabetes. (1 August 2004)
  179. Caffeine interferes with diabetes control - US study. (Cites Diabetes Care 27:2047-2048, 2004.) (1 August 2004)
  180. Therapy with adjunctive doxycycline local delivery in patients with type 1 diabetes mellitus and periodontitis. (1 August 2004)
  181. Prevention of adverse events in juvenile diabetes. Free full text available in PDF format. (25 July 2004)
  182. Preschoolers are not miniature adolescents: a comparison of insulin pump doses in two groups of children with type 1 diabetes mellitus. (25 July 2004)
  183. Rediscovery of insulin pump treatment of childhood type 1 diabetes. (25 July 2004)
  184. Empowerment and Self-Management of Diabetes. (25 July 2004)
  185. Integration of Clinical Psychology in the Comprehensive Diabetes Care Team. (25 July 2004)
  186. Case Study: Treating Hypertension in Patients With Diabetes. (25 July 2004)
  187. Case Study: Alteration in Run Performance and Aerobic Power in a Runner With Type 1 Diabetes. (25 July 2004)
  188. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. (25 July 2004)
  189. Nutrition and Pregnancy: The Link Between Dietary Intake and Diabetes. (25 July 2004)
  190. Electrical stimulation therapy through stocking electrodes for painful diabetic neuropathy: a double blind, controlled crossover study. (25 July 2004)
  191. Diabetic retinopathy screening should be top priority, MD says. (25 July 2004)
  192. Assessment Of Therapy With Continuous Subcutaneous Insulin Infusion In An Academic Diabetes Clinic. (18 July 2004)
  193. Comparison between continuous subcutaneous insulin infusion and multiple insulin injection therapy in type 1 diabetes mellitus: 18-month follow-up. (18 July 2004)
  194. Once-daily insulin glargine compared with twice-daily nph insulin in patients with type 1 diabetes. (18 July 2004)
  195. Blood glucose monitoring technology: translating data into practice. (18 July 2004)
  196. Effect Of Intensive Insulin Therapy On Progression Of Overt Nephropathy In Patients With Type 1 Diabetes Mellitus. (18 July 2004)
  197. Glucose and insulin requirements during labor and delivery: the case for normoglycemia in pregnancies complicated by diabetes. (18 July 2004)
  198. Recent advances in diabetic nephropathy. (18 July 2004)
  199. Glycemic Patterns Detected by Continuous Subcutaneous Glucose Sensing in Children and Adolescents With Type 1 Diabetes Mellitus Treated by Multiple Daily Injections vs Continuous Subcutaneous Insulin Infusion. (11 July 2004)
  200. Diabetes management by hospital-affiliated diabetes centres in Lazio, Italy. (11 July 2004)
  201. Improvements in Insulin Resistance with Aerobic Exercise Training: A Lipocentric Approach. (11 July 2004)
  202. Introduction-Preventing Insulin Resistance through Exercise: A Cellular Approach. (11 July 2004)
  203. Toolkit: ABCDEFGs of Diabetes. (11 July 2004)
  204. Effectiveness Of A Disease Management Program For Patients With Diabetes. See also Newly Released National Study Shows Diabetes Disease Management Program Reduces Costs, Improves Quality. (11 July 2004)
  205. We've published a response to the Countdown article that included a sidebar critical of nighttime blood glucose testing. (4 July 2004)
  206. Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. (4 July 2004)
  207. Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen. (4 July 2004)
  208. Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes. (4 July 2004)
  209. Motor activity during asymptomatic nocturnal hypoglycemia in adolescents with type 1 diabetes mellitus. (4 July 2004)
  210. Effects of low and moderate antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes. (4 July 2004)
  211. Characteristics and learning effects of the predictability of the self-monitored blood glucose level in children with type 1 diabetes. (4 July 2004)
  212. The effect of preapplication of corticosteroids on skin irritation and performance of the GlucoWatch G2 Biographer. (4 July 2004)
  213. The utility of insulin glargine in the treatment of diabetes mellitus. (4 July 2004)
  214. Postprandial Administration of Insulin Lispro May Be Effective Alternative for Pregnant Diabetic Women with Nausea/Vomiting. (4 July 2004)
  215. Pregnancy in women with type 2 diabetes: an uncertain prognosis. (4 July 2004)
  216. Psychosocial predictors of relapse among diabetes patients: a 2-year follow-up after inpatient diabetes education. (4 July 2004)
  217. Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes. (27 June 2004)
  218. A Randomized, Prospective Trial Comparing the Efficacy of Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections Using Insulin Glargine. (27 June 2004)
  219. Effects of Low and Moderate Antecedent Exercise on Counterregulatory Responses to Subsequent Hypoglycemia in Type 1 Diabetes. (27 June 2004)
  220. Helping other mothers effectively work at raising young children with type 1 diabetes. (27 June 2004)
  221. Peer victimization and psychosocial adjustment in children with type 1 diabetes. (27 June 2004)
  222. Poor glycemic control is associated with increased diastolic blood pressure and heart rate in children with Type 1 diabetes. (27 June 2004)
  223. Cerebral Edema in Childhood Diabetic Ketoacidosis. (27 June 2004)
  224. Improved Glycemic Control Without Weight Gain Using Triple Therapy in Type 2 Diabetes. (27 June 2004)
  225. Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus. (20 June 2004)
  226. What does postprandial hyperglycaemia mean? (20 June 2004)
  227. A randomised controlled trial of insulin lispro given before or after meals in pregnant women with Type 1 diabetes--the effect on glycaemic excursion. (20 June 2004)
  228. Closing the loop: the adicol experience. (20 June 2004)
  229. Comparison of a low-fat diet to a low-carbohydrate diet on weight loss, body composition, and risk factors for diabetes and cardiovascular disease in free-living, overweight men and women. (20 June 2004)
  230. Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: Results of the Diabetes Research in Children Network (DirecNet) accuracy study. (13 June 2004)
  231. A prospective study of severe hypoglycemia and long-term spatial memory in children with type 1 diabetes. (13 June 2004)
  232. Insulin pumps benefit children. (13 June 2004)
  233. Reducing injection pain in children and adolescents with diabetes: a review of indwelling catheters. (13 June 2004)
  234. Initiation of insulin glargine in children and adolescents with type 1 diabetes. (13 June 2004)
  235. Insulin Lispro Injection (Humalog) for Use in External Insulin Pumps. (13 June 2004)
  236. A developmental perspective on the challenges of diabetes education and care during the young adult period. (13 June 2004)
  237. Continuous glucose monitoring: which benefits? (13 June 2004)
  238. Get aggressive with diabetics' BP. (13 June 2004)
  239. Forearm blood glucose testing in diabetes mellitus. See also Children, Teens Prefer Forearm Glucose Testing. (6 June 2004)
  240. Why Pumps? Continuous Subcutaneous Insulin Infusion for Children and Adolescents with Type 1 Diabetes. (6 June 2004)
  241. Insulin Pump Therapy for 1-6 Year Old Children with Type 1 Diabetes. Full text available in PDF format. (6 June 2004)
  242. Diabetes conundrum: Can control be too tight? (6 June 2004)
  243. Diabetes and physical activity in school. (6 June 2004)
  244. Atypical Antipsychotics and Diabetes Mellitus: An Association. (6 June 2004)
  245. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes. (30 May 2004)
  246. Lower Within-Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 Diabetes. (30 May 2004)
  247. A questionnaire survey on the use of quick-acting insulin analog in Japanese children and adolescents with type 1 diabetes. (30 May 2004)
  248. Accuracy of blood glucose estimation by children with diabetes: an investigation of repeated practice with growth curve modeling. (30 May 2004)
  249. Forearm blood glucose testing in diabetes mellitus. (30 May 2004)
  250. The Coping Styles of Adolescents With Type 1 Diabetes Are Associated With Degree of Metabolic Control . (30 May 2004)
  251. An initial evaluation of the design of pediatric psychology consultation service with children with diabetes. (30 May 2004)
  252. Management of diabetes in childhood: are children small adults? (30 May 2004)
  253. Oral Hypoglycemic Agents in Pregnancy. (30 May 2004)
  254. Glyburide for the treatment of gestational diabetes. (30 May 2004)
  255. Insulin pump therapy for 1-6 year old children with type 1 diabetes. (23 May 2004)
  256. Childhood diabetes: parents' experience of home management and the first year following diagnosis. (23 May 2004)
  257. The impact of cognitive distortions, stress, and adherence on metabolic control in youths with type 1 diabetes. (23 May 2004)
  258. Prevalence and clinical manifestations of eating disorders in Austrian adolescents with type-1 diabetes. (23 May 2004)
  259. Stressors and self-care challenges faced by adolescents living with type 1 diabetes. (23 May 2004)
  260. An assessment of the adequacy of suspension of insulin in pen injectors. (23 May 2004)
  261. Nipro Diabetes Systems Recalls Amigo Pumps (16 May 2004)
  262. BD Discontinues BD Pen Mini and BD Pen. (16 May 2004)
  263. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness. (16 May 2004)
  264. Continuous Subcutaneous Insulin Infusion: Short-Term Benefits Apparent, Long-Term Benefits Speculative. (16 May 2004)
  265. Current perspectives on the use of continuous subcutaneous insulin infusion in the acute care setting and overview of therapy. (16 May 2004)
  266. Diabetes in childhood: burden and professional consequences for parents. (16 May 2004)
  267. Child behavior problems and family functioning as predictors of adherence and glycemic control in economically disadvantaged children with type 1 diabetes: a prospective study. (16 May 2004)
  268. Parenting adolescent girls with type 1 diabetes: parents' perspectives. (16 May 2004)
  269. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. Also in PDF format. See also A third of type 1 diabetics have renal damage within 20 years. (16 May 2004)
  270. The first generation of e-patients. (16 May 2004)
  271. Health related virtual communities and electronic support groups: systematic review of the effects of online peer to peer interactions. (16 May 2004)
  272. Patients' experience with a diabetes support programme based on an interactive electronic medical record: qualitative study. (16 May 2004)
  273. Patients with type 2 diabetes should take statins. (16 May 2004)
  274. Predictors of control of diabetes: Monitoring may be the key. (16 May 2004)
  275. Insulin pump benefits preschoolers with diabetes. (9 May 2004)
  276. Teaching families to work together improves diabetes management for low income kids, UMHS study finds. See also Families working together improves diabetes management for low income kids, study finds. (9 May 2004)
  277. Eye care in African Americans with type 1 diabetes; The New Jersey 725. (9 May 2004)
  278. Should we continue or stop insulin sensitizing drugs during pregnancy? (9 May 2004)
  279. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. (9 May 2004)
  280. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management. (9 May 2004)
  281. Insulin Detemir Offers Improved Glycemic Control Compared With NPH Insulin in People With Type 1 Diabetes. (2 May 2004)
  282. What is the relative contribution of blood glucose levels at different time points of the day to HbA in Type 1 diabetes? (2 May 2004)
  283. A Direct Efficacy and Safety Comparison of Insulin Aspart, Human Soluble Insulin, and Human Premix Insulin (70/30) in Patients With Type 2 Diabetes. (2 May 2004)
  284. Short-Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes . (2 May 2004)
  285. Treatment of Diabetic Gastroparesis by High-Frequency Gastric Electrical Stimulation. (2 May 2004)
  286. A double-blind study comparing 0.5% and 1% tropicamide for annual retinal screening in diabetic adolescents. (2 May 2004)
  287. Cost-effectiveness of flexible intensive insulin management to enable dietary freedom in people with Type 1 diabetes in the UK. (2 May 2004)
  288. Influence of Caffeine on Heart Rate Variability in Patients With Long-Standing Type 1 Diabetes. (2 May 2004)
  289. Recognizing and treating depression in patients with diabetes. (2 May 2004)
  290. Diabetes, Depression, and Quality of Life. (2 May 2004)
  291. Telecare for Patients With Type 1 Diabetes and Inadequate Glycemic Control. (2 May 2004)
  292. Cost-Effectiveness Analysis of Telemedicine to Evaluate Diabetic Retinopathy in a Prison Population. (2 May 2004)
  293. Effect of macronutrient intake on the development of glucose intolerance during pregnancy. (2 May 2004)
  294. Consequences of smoking and caffeine consumption during pregnancy in women with type 1 diabetes. (25 April 2004)
  295. Assessment of hypoglycaemia awareness using continuous glucose monitoring. (25 April 2004)
  296. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. (25 April 2004)
  297. Anaemia in diabetes. (25 April 2004)
  298. Aventis Receives FDA Approval of its Rapid-Acting Insulin Analogue Apidra®. (25 April 2004)
  299. Patient perception and use of an insulin injector/glucose monitor combined device. (25 April 2004)
  300. Preparing students with diabetes for life at college. (25 April 2004)
  301. Dietary advice for treatment of type 2 diabetes mellitus in adults. (25 April 2004)
  302. The protective effects of ascorbic acid on arterial haemodynamics during acute hyperglycaemia. (18 April 2004)
  303. ImmunoDip: An Improved Screening Method for Microalbuminuria. (18 April 2004)
  304. Insulin pumps: what every school nurse needs to know. (11 April 2004)
  305. Preprandial vs. postprandial insulin lispro-a comparative crossover trial in patients with Type 1 diabetes. See also Postprandial Insulin Lispro Is Effective But May Impair Long-Term Glycaemic Control. (11 April 2004)
  306. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. Full text available in PDF. (11 April 2004)
  307. Folic acid improves endothelial function in children and adolescents with type 1 diabetes. (11 April 2004)
  308. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy. (11 April 2004)
  309. Diabetic neuropathy in children and adolescents. (11 April 2004)
  310. Hospital Management of Hyperglycemia. (11 April 2004)
  311. Diabetes Potpourri: Nomenclature and Glycemia. (11 April 2004)
  312. The Future of Diabetes: What Is There Besides New Medicines? (11 April 2004)
  313. Coping skills training and problem solving in diabetes. (11 April 2004)
  314. TheraSense study shows equivalence between blood from a finger and blood from the palm at the base of the thumb even during periods of rapidly changing blood glucose. (11 April 2004)
  315. Recurrent hypoglycaemia in a diabetic patient as a result of unexpected renal failure. Also in PDF format. (11 April 2004)
  316. Early Glycemic Control, Age at Onset, and Development of Microvascular Complications in Childhood-Onset Type 1 Diabetes. (4 April 2004)
  317. Eighteen Years of Fair Glycemic Control Preserves Cardiac Autonomic Function in Type 1 Diabetes. (4 April 2004)
  318. A quality-of-life assessment of intensive insulin therapy using insulin lispro switched from short-acting insulin and measured by an ITR-QOL questionnaire: a prospective comparison of multiple daily insulin injections and continuous subcutaneous insulin infusion. (4 April 2004)
  319. Bedside ketone determination in diabetic children with hyperglycemia and ketosis in the acute care setting. (4 April 2004)
  320. Evidence for a vicious cycle of exercise and hypoglycemia in type 1 diabetes mellitus. (4 April 2004)
  321. Effects of Health Maintenance Organization Coverage of Self-monitoring Devices on Diabetes Self-care and Glycemic Control. (4 April 2004)
  322. Continuous glucose monitoring in type 1 diabetes. (4 April 2004)
  323. "Expert patient"—dream or nightmare? (4 April 2004)
  324. A Short History of Pediatric Endocrinology in North America. (4 April 2004)
  325. Periodontal health, salivary status, and metabolic control in children with type 1 diabetes mellitus. (28 March 2004)
  326. Statin treatment and the natural history of atherosclerotic-related diseases: pathogenic mechanisms and the risk-benefit profile. (28 March 2004)
  327. The Centers for Disease Control offers guidance on Safe Community Needle Disposal. (28 March 2004)
  328. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. (21 March 2004)
  329. Thinner needles do not influence injection pain, insulin leakage or bleeding in children and adolescents with type 1 diabetes. (21 March 2004)
  330. Characteristics of glycemic control in young children with type 1 diabetes. (21 March 2004)
  331. Sweet dreams? - nocturnal hypoglycemia in children with type 1 diabetes. (21 March 2004)
  332. Treatment of hypertension and microalbuminuria in children and adolescents with type 1 diabetes mellitus. (21 March 2004)
  333. Linear growth and height outcomes in children with early onset type 1 diabetes mellitus - a 10-yr longitudinal study. (21 March 2004)
  334. Lilly to withdraw four insulins from the UK market. (21 March 2004)
  335. Insulin lispro versus regular insulin in children with type 1 diabetes on twice daily insulin. (21 March 2004)
  336. Sources of errors in blood glucose self-monitoring in 100 young diabetics. (21 March 2004)
  337. Does the school nurse-to-student ratio make a difference? (21 March 2004)
  338. MiniMed Reports Problems with Paradigm QuickSet Plus. (14 March 2004)
  339. An ambulatory stabilisation program for children with newly diagnosed type 1 diabetes. (14 March 2004)
  340. Study examined whether fetal hemoglobin levels typically seen in type 1 diabetes (up to 3%) interfere with glycohemoglobin determinations using a common method. (14 March 2004)
  341. Study examined the impact of glucose monitoring on control in patients with type 1 and type 2 diabetes at a clinic in Poland. (14 March 2004)
  342. Treatment of patients with severe insulin deficiency; what we have learned over the past 2 years. (14 March 2004)
  343. Coffee Consumption and Risk of Type 2 Diabetes Mellitus Among Middle-aged Finnish Men and Women. See also Coffee Cuts Diabetes Risk. (14 March 2004)
  344. Blowing the whistle on review articles: What should we know about the treatment of type 2 diabetes? . (14 March 2004)
  345. Children say they are not involved enough in their treatment. (14 March 2004)
  346. Antipsychotics' Diabetes Risk Prompts Call for Better Assessment. See also Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes from the American Diabetes Association. (14 March 2004)
  347. Intragam can interfere with blood glucose monitoring. (14 March 2004)
  348. Neonatal and very-early-onset diabetes mellitus. (14 March 2004)
  349. Timely initiation of basal insulin. (14 March 2004)
  350. Influence of resistance exercise training on glucose control in women with type 2 diabetes. (14 March 2004)
  351. Improving Oral Pharmacologic Treatment And Management of Type 2 Diabetes. (14 March 2004)
  352. Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. (14 March 2004)
  353. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. (7 March 2004)
  354. Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump. (7 March 2004)
  355. The direct measurement of 3-beta-hydroxy butyrate enhances the management of diabetic ketoacidosis in children and reduces time and costs of treatment. (This study is about the positive impact of using the Precision Extra for blood ketone testing.) (7 March 2004)
  356. The lived experience of adolescent females with type 1 diabetes. (7 March 2004)
  357. Is carotid ultrasound a useful tool in assessing cardiovascular disease in individuals with diabetes? (7 March 2004)
  358. Informal diabetes education: impact on self-management and blood glucose control. (7 March 2004)
  359. Little time for diabetes management in the primary care setting. (7 March 2004)
  360. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. (7 March 2004)
  361. Accuracy of the GlucoWatch G2 Biographer and the Continuous Glucose Monitoring System During Hypoglycemia: Experience of the Diabetes Research in Children Network. Free full text available in HTML or PDF format. (29 February 2004)
  362. Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults With Type 1 Diabetes. (29 February 2004)
  363. Food cravings during acute hypoglycaemia in adults with Type 1 diabetes. (29 February 2004)
  364. Preprandial vs. postprandial insulin lispro: a comparative crossover trial in patients with Type 1 diabetes. (29 February 2004)
  365. Influence of alcohol on cognitive performance during mild hypoglycaemia; implications for Type 1 diabetes. (29 February 2004)
  366. Street drug use among young patients with Type 1 diabetes in the UK. (29 February 2004)
  367. Metabolic Control in Adolescent Girls. (29 February 2004)
  368. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study). See also Low dose ramipril is not optimal in diabetes. (29 February 2004)
  369. Impaired Pressure-Induced Vasodilation at the Foot in Young Adults With Type 1 Diabetes. (29 February 2004)
  370. Novo Nordisk receives positive opinion on Levemir(TM) (insulin detemir) from EU committee. See also European Union Grants Positive Opinion to Levemir (Insulin Detemir), Long-Acting Insulin Analog and Novo insulin backed by EU experts, shares rise. (29 February 2004)
  371. Impact of Iron Deficiency Anemia on Prevalence of Gestational Diabetes Mellitus. (29 February 2004)
  372. The current issue of the British Medical Journal is devoted to things that don't work and offers several interesting editorials about medicine and medical research, including:
    1. What doesn't work and how to show it. (29 February 2004)
    2. Why do doctors use treatments that do not work? (29 February 2004)
    3. Absence of evidence is not evidence of absence. (29 February 2004)
  373. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. (22 February 2004)
  374. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents. Also in PDF format. (22 February 2004)
  375. Extreme subcutaneous insulin resistance: a misunderstood syndrome. (22 February 2004)
  376. Periodontal health, salivary status, and metabolic control in children with type 1 diabetes mellitus. (22 February 2004)
  377. Perioperative management of diabetic patients. (22 February 2004)
  378. Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. (22 February 2004)
  379. Asian-Americans don't have to be heavy to develop diabetes. See also Type 2 Diabetes Prevalence in Asian Americans. (22 February 2004)
  380. A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8). (15 February 2004)
  381. Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. (15 February 2004)
  382. Medscape Coverage of the 18th International Diabetes Federation Congress includes many excellent articles, including:
    1. Insulin Treatment: New Technology, New Preparations. (15 February 2004)
    2. Blood Glucose Monitoring. (15 February 2004)
    3. Intensive Management of Type 1 Diabetes. (15 February 2004)
    4. Living With Diabetes. (15 February 2004)
    5. Task Force Calls for Solutions to Inadequate Global Insulin Supply. (15 February 2004)
  383. New Technologies for Monitoring Metabolic Control of Diabetes in Children and Adolescents. (Free registration required) (15 February 2004)
  384. Quality of Life for Adolescents With Type I Diabetes: Parental and Youth Perspectives (15 February 2004)
  385. Reimbursement for Pediatric Diabetes Intensive Case Management: A Model for Chronic Diseases? Free full text online as HTML or PDF. (8 February 2004)
  386. A Short History of Pediatric Endocrinology in North America. (8 February 2004)
  387. Habitual fish consumption and glycated haemoglobin: The EPIC-Norfolk Study. (8 February 2004)
  388. Home Blood Pressure Monitoring and Diabetes. (8 February 2004)
  389. Checking Your Blood Pressure at Home. (8 February 2004)
  390. Obesity in America: It’s Getting Worse. (8 February 2004)
  391. Osteoporosis: An Under-appreciated Complication of Diabetes. (8 February 2004)
  392. Resistance exercise decreases the need for insulin in overweight women with gestational diabetes mellitus. (8 February 2004)
  393. Nutrition and diabetes focuses on type 2 diabetes. (8 February 2004)
  394. Management of Diabetes and Hyperglycemia in Hospitals. (1 February 2004)
  395. Health-Related Quality of Life and Metabolic Control in Children With Type 1 Diabetes. (1 February 2004)
  396. Establishment of Blood Glucose Monitoring System Using the Internet. (1 February 2004)
  397. Placental growth hormone during pregnancy in a growth hormone deficient woman with type 1 diabetes compared to a matching diabetic control group. (1 February 2004)
  398. The Role of Autonomy and Pubertal Status in Understanding Age Differences in Maternal Involvement in Diabetes Responsibility across Adolescence. (1 February 2004)
  399. Role of smoking and HbA1c level in periodontitis among insulin-dependent diabetic patients. (1 February 2004)
  400. A Randomized Trial Evaluating a Predominately Fetal Growth–Based Strategy to Guide Management of Gestational Diabetes in Caucasian Women. (1 February 2004)
  401. Cardiac Abnormalities in Diabetic Patients With Neuropathy: Effects of aldose reductase inhibitor administration. (1 February 2004)
  402. Treatment of Type 2 Diabetes in Childhood Using a Very-Low-Calorie Diet. (1 February 2004)
  403. A Prospective Study of Glycemic Control During Holiday Time in Type 2 Diabetic Patients. (1 February 2004)
  404. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. (1 February 2004)
  405. Vaccinations against influenza and pneumococcus in children with diabetes: telephone questionnaire survey. (25 January 2004)
  406. A comparison between optimal and actuarial health care costs of adolescents with diabetes. (25 January 2004)
  407. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. (25 January 2004)
  408. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. (25 January 2004)
  409. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. See also Most People with Diabetes Do Not Meet Treatment Goals. (25 January 2004)
  410. Technology Failure Analysis: Understanding Why a Diabetes Management Tool Developed for a Personal Digital Assistant (PDA) Didn't Work in a Randomized Controlled Trial. (25 January 2004)
  411. Rewarming index of the lower leg assessed by infrared thermography in adolescents with type 1 diabetes mellitus. (25 January 2004)
  412. Pregnancy and type 2 diabetes: which fetal prognosis? (25 January 2004)
  413. Viewpoint: Internet-based Patient Self-care: The Next Generation of Health Care Delivery. (25 January 2004)
  414. Design and Testing of a Tool for Evaluating the Quality of Diabetes Consumer-Information Web Sites. (25 January 2004)
  415. Rethinking management of chronic diseases. (25 January 2004)
  416. Chronic disease care. (25 January 2004)
  417. Metformin and serious adverse effects. (25 January 2004)
  418. Long-acting sulfonylureas — long-acting hypoglycaemia. (25 January 2004)
  419. Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits. (25 January 2004)
  420. Abbott Laboratories To Acquire TheraSense. (18 January 2004)
  421. Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. (18 January 2004)
  422. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. See also Patients Prefer Disposable Insulin-Injection Pen to Conventional Vial/Syringe Delivery Method. (18 January 2004)
  423. Quality of life for adolescents with type 1 diabetes: parental and youth perspectives. (18 January 2004)
  424. A comparison between optimal and actuarial health care costs of adolescents with diabetes. (18 January 2004)
  425. The Impact of Diabetic Retinopathy on Participation in Daily Living. See also Measuring the Effects of Vision Loss. (18 January 2004)
  426. Angiotensin receptor blockers as anti-hypertensive treatment for patients with diabetes mellitus: meta-analysis of controlled double-blind randomized trials. (18 January 2004)
  427. Treating Foot Infections in Diabetic Patients: A Randomized, Multicenter, Open-Label Trial of Linezolid versus Ampicillin-Sulbactam/Amoxicillin-Clavulanate. See also Linezolid surpasses other antibiotics for diabetic foot ulcers and Study finds new antibiotic effective for diabetic foot infections. (18 January 2004)
  428. In Is there sustained renal benefit from previous intensive insulin therapy in people with type 1 diabetes? author Steven L. Shumak concludes that "... all patients with type 1 diabetes should be considered for intensive insulin therapy." (11 January 2004)
  429. A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8). (11 January 2004)
  430. School professionals' perceptions about the impact of chronic illness in the classroom. (11 January 2004)
  431. A multicenter study of the accuracy of the One Touch Ultra home glucose meter in children with type 1 diabetes. (11 January 2004)
  432. Alternative site blood glucose testing: a multicenter study. (11 January 2004)
  433. Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS). (11 January 2004)
  434. "Sweet Talk": text messaging support for intensive insulin therapy for young people with diabetes. (11 January 2004)
  435. The use of information technology for the management of intensive insulin therapy in type 1 diabetes mellitus. (11 January 2004)
  436. Children are not small adults. (11 January 2004)
  437. Pediatric diabetic ketoacidosis. (11 January 2004)
  438. Sudden hearing loss as a first complication of long-standing Type 1 diabetes mellitus: a case report. (11 January 2004)
  439. Use of the Cygnus GlucoWatch Biographer at a Diabetes Camp. (4 January 2004)
  440. Change in glycemic control predicts change in weight in adolescent boys with type 1 diabetes. (4 January 2004)
  441. Insulin glargine versus NPH insulin in patients with type 1 diabetes. (4 January 2004)
  442. Gestational Diabetes Mellitus: The Case for Euglycemia. (4 January 2004)
  443. Making the Case for Euglycemia in Women With Gestational Diabetes Mellitus. (4 January 2004)
  444. Diabetes self-management: how are we doing? (4 January 2004)
  445. Omega 3 fatty acids and cardiovascular disease—fishing for a natural treatment. (4 January 2004)

[ Current Daily Care News | News from 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]



                 
  Home Return to Top

Last Updated: Thursday January 01, 2015 15:28:56
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2015. Comments and Feedback.